Double-blind Trial of Mannitol Cream to Block the Effect of Capsaicin Cream
NCT ID: NCT01963910
Last Updated: 2014-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2013-12-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mannitol Cream for Post Herpetic Neuralgia
NCT02484170
Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
NCT00528216
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream
NCT01883102
Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol
NCT03132142
The Role of TRP Channels in CIPN
NCT04415892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mannitol in vehicle cream
Once the capsaicin has been removed, .2 mL of 30% mannitol in vehicle cream will be applied to one half of the upper lip and kept there for 10 minutes.
30% Mannitol in vehicle cream
applied to one half of the upper lip following removal of capsaicin cream.
Vehicle Cream
Once the capsaicin has been removed, .2 mL of vehicle cream will be applied to the other half of the upper lip and kept there for 10 minutes.
vehicle cream
application to the other half of the upper lip following capsaicin cream removal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
30% Mannitol in vehicle cream
applied to one half of the upper lip following removal of capsaicin cream.
vehicle cream
application to the other half of the upper lip following capsaicin cream removal
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Meal containing capsaicin (spicy foods) within 5 days prior to the experiment.
* Any lesion, cracking, cold sore or abrasion on the lips
* Inability to tolerate capsaicin containing "spicy foods"
* Wearing lipstick or lip balm on the upper lip
* Inability to fill out an NRS pain scale
* Use of painkilling medication, within 24 hours of the study.
* Allergy to any of the ingredients of the creams, or to mannitol
* History of contact or allergic dermatitis
* Pregnant or nursing women
19 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helene Bertrand
Clinical instructor Department of Family Practice
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helene Bertrand, MD, CM, CCFP
Role: PRINCIPAL_INVESTIGATOR
Department of family practice, University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Helene Bertrand Inc., 220-1940 Lonsdale Ave.
North Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ngom PI, Dubray C, Woda A, Dallel R. A human oral capsaicin pain model to assess topical anesthetic-analgesic drugs. Neurosci Lett. 2001 Dec 28;316(3):149-52. doi: 10.1016/s0304-3940(01)02401-6.
Boudreau SA, Wang K, Svensson P, Sessle BJ, Arendt-Nielsen L. Vascular and psychophysical effects of topical capsaicin application to orofacial tissues. J Orofac Pain. 2009 Summer;23(3):253-64.
Bertrand H, Kyriazis M, Reeves KD, Lyftogt J, Rabago D. Topical Mannitol Reduces Capsaicin-Induced Pain: Results of a Pilot-Level, Double-Blind, Randomized Controlled Trial. PM R. 2015 Nov;7(11):1111-1117. doi: 10.1016/j.pmrj.2015.05.002. Epub 2015 May 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H13-01551
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.